- Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer. Pérez Carrión, R., Alberola Candel, V., Calabresi, F., Michel, R.T., Santos, R., Delozier, T., Goss, P., Mauriac, L., Feuilhade, F., Freue, M. Ann. Oncol. (1994)